α-Lipoic acid supplementation: A tool for obesity therapy?

Current Pharmaceutical Design

Volumn 16, Issue 7, 2010, Pages 840-846

  Carbonelli, M G ^a   Di Renzo, L ^b,c   Bigioni, M ^b   Di Daniele, N ^b   De Lorenzo, A ^b,c   Fusco, M A ^a  

^a SAN CAMILLO FORLANINI HOSPITAL   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

^c INDiM   (Italy)

Author keywords

lipoic acid; BMI; Body composition; LA DHLA; Obesity

Indexed keywords

LIPONAX; THIOCTIC ACID; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD PRESSURE; BODY MASS; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL; WAIST CIRCUMFERENCE; WEIGHT REDUCTION;

ADOLESCENT; ADULT; ANTIOXIDANTS; BLOOD PRESSURE; BODY MASS INDEX; BODY WEIGHT; DIETARY SUPPLEMENTS; FEMALE; HUMANS; LIPID PEROXIDATION; MALE; MIDDLE AGED; OBESITY; OXIDATION-REDUCTION; REACTIVE OXYGEN SPECIES; THIOCTIC ACID; YOUNG ADULT;

EID: 77950231257     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/138161210790883589     Document Type: Article

References (48)

1. De Ferranti S, Mozaffarian D. The perfect storm: obesity, adipocyte dysfunction, and metabolic consequences. Clin Chem 2008; 54: 945-955.
2. Cooke D, Bloom S. The obesity pipeline: current strategies in the development of anti-obesity drugs. Nat Rev Drug Discov 2006, 5: 919-931
3. Kim MS, Park JY, Namkoong C, Jang PG, Ryu JW, Song HS, et al. Anti-obesity effects of α-lipoic acid mediated by suppression of hypothalamic AMP-activated protein kinase. Nat Med 2004; 10: 727-733
4. Doggrell SA. A-Lipoic acid, an anti-obesity agent? Exp Opin Investig Drug 2004; 13: 1641-1643
5. Bilska A, Wodek L. Lipoic acid - the drug of the future? Pharmacol Rep 2005; 57: 570-577
6. Diet, nutrition and the prevention of chronic diseases, Word Health Organ Technol Rep Ser 2003; 916: 1-149.
7. Lohman TG, Roche AF, Martorell R. Anthropometric standardization reference manual. Human Champaign, Human Kinetics Books 1998.
8. De Lorenzo A, Andreoli A, Candeloro N. Within-subject variability in body composition using dual-energy X-ray absorptiometry (DXA). Clin Physiol 1997; 17: 383-384
9. Wilson MM, Thomas DR, Rubenstein LZ, Chibnall JT, Anderson S, Amy Baxi, et al. Appetite assessment: simple appetite questionnaire predicts weight loss in community-dwelling adults and nursing home residents. Am J Clin Nutr 2005; 82: 1074-1081
10. Gortmaker SL, Peterson K, Wiecha J, Sobol AM, Dixit S, Fox MK, et al. Reducing obesity via a school-based interdisciplinary intervention among youth: planet health. Arch Pediatr Adolesc Med 1999; 153: 409-418
11. WHO OBESITY. Preventing and managing the global epidemic. Report on a WHO Consultation of Obesity. Geneva, Switzerland, 3-5 June, WHO/NUT/ NCD/98.1 1998.
12. Fernàndez-Real JM, Ricart W. Insulin resistance and chronic cardiovascular inflammatory syndrome. Endoc Rev 2003; 24: 278-301.
13. Juge-Aubry CE, Henrichot E, Meier CA. Adipose tissue: a regulator of inflammation. Best Pract Res Clin Endocrinol Metab 2005; 19: 547-566
14. Shoelson SE, Lee J, Goldfine AB. Inflammation and insulin resistance. J Clin Invest 2006; 116: 1793-1801
15. Festa A, D'Agostino R, Jr, Rautaharju P, Mykkanen L, Haffner. Relation of systemic blood pressure, left ventricular mass, insulin sensitivity, and coronary artery disease to QT interval duration in non diabetic and type 2 diabetic subjects. Am J Cardiol 2000; 86: 1117-1122
16. Alberti KG, Zimmet P, Shaw J. IDF Epidemiology Task Force Consensus Group. The metabolic syndrome - a new worldwide definition. Lancet 2005; 366: 1059-1062
17. Haffner S, Taegtmeyer H. Epidemic obesity and the metabolic syndrome. Circulation 2003; 108: 1541-1545
18. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, lung, and blood institute scientific statement. Circulation 2005; 112: 2735-2752
19. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet 2005; 365: 1415-1428
20. Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002; 288: 2709-2716
21. Ridker PM, Buring JE, Cook NR, Rifai N. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women. Circulation 2003; 107: 391-397
22. Festa A, D'Agostino R, Jr, Howard G, Mykkanen L, Tracy RP, Haffner SM. Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation 2000; 102: 42-47
23. Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults - the Evidence Report. National Institutes of Health. Obes Res 1998; 6: 51S-209S.
24. Teichert J, Hermann R, Ruus P, Preiss R. Plasma kinetics, metabolism, and urinary excretion of α-lipoic acid following oral administration in healthy volunteers. J Clin Pharmacol 2003; 43: 1257-1267
25. Thirunavukkarasu V, Anitha Nandhini AT, Anuradha CV. Lipoic acid attenuates hypertension and improves insulin sensitivity, kallikrein activity and nitrite levels in high fructose-fed rats. J Comp Physiol (B) 2004; 174: 587-592
26. Vasdev S, Ford CA, Parai S, Longerich L, Gadag V. Dietary lipoic acid supplementation prevents fructose-induced hypertension in rats. Nutr Metab Cardiovasc Dis 2000; 10: 339-346
27. Lee WJ, Lee IK, Kim HS, Kin JM, Koh EH, Won JC, et al. α-lipoic acid prevents endothelial dysfunction in obese rats via activation of AMP-activated protein kinase. Arterioscler Thromb Vasc Biol 2005; 25: 2488-2494
28. Lehrke M, Lazar MA. The many faces of PPARγ. Cell 2005; 123: 993-999
29. Berger JP, Petro AE, Macnaul KL, Kelly LJ, Zhang BB, Richards K, et al. Distinct properties and advantages of a novel peroxisome proliferator-activated protein (gamma) selective modulator. Mol Endocrinol 2003; 17: 662-676
30. Bustamante J, Lodge JK, Marcocci L, Tritschler HJ, Packer L, Rihn BH. α-lipoic acid in liver metabolism and disease. Free Radic Biol Med 1998; 24: 1023-1039
31. Vasdev S, Ford CA, Parai S, Longerich L, Gadav V. Dietary α-lipoic acid supplementation lowers blood pressure in spontaneously hypertensive rats. J Hypertens 2000; 18: 567-573
32. Vasdev S, Gill V, Longerich L, Parai D, Gadav V. Salt-induced hypertension in WKY rats: prevention by α-lipoic acid supplementation. Mol Cell Biochem 2003; 254: 319-326
33. Buttke TM, Sandstrom PA. Redox regulation of programmed cell death in lymphocytes. Free Radic Res 1995; 22: 389-397
34. Deneke SM. Thiol-based antioxidants. Curr Top Cell Regul 2000; 36: 151-180
35. Tardif JC, Rheaume E. Lipoic acid supplementation and endothelial function. Br J Pharmacol 2008; 153: 1587-1588
36. Keyse SM, Tyrrel RM. Heme oxygenase is the major 32-kDa stress protein induced in human skin fibroblasts by UVA radiation, hydrogen peroxide, and sodium arsenite. Proc Natl Acad Sci USA 1989; 86: 99-103.
37. Dovinova I, Novotny L, Rauko P, Kvasnicka P. Combined effect of lipoic acid and doxorubicyn in murine leukemia. Neoplasma 1999; 46: 237-241
38. Sola S, Mir MQS, Cheema FA, Khan-Merchant N, Menon RG, Parthasarathy S, et al. Irbesartan and lipoic acid improve endothelial function and reduce markers of inflammation in the metabolic syndrome. Circulation 2005; 111: 343-348
39. Lee KM, Park KG, Kim YD. α-Lipoic acid inhibits fractalkine expression and prevents neointimal hyperplasia after balloon injury in rat carotid artery. Atherosclerosis 2006; 189: 106-114
40. Kamimura D, Ishihara K, Hirano T. IL-6 signal transduction and its physiological roles: the signal orchestration model. Rev Physiol Biochem Pharmacol 2003; 149: 1-38.
41. Shoelson SE, Lee J, Goldfine AB. Inflammation and insulin resistance. J Clin Invest 2006; 116: 1793-1801
42. Di Renzo L, Aldo Bertoli A, Bigioni M, Del Gobbo V, Premrov MG, Vittorio Calabrese V, et al. Body composition and 174G/C Interleukine-6 promoter gene polymorphism: association with progression of insulin resistance in Normal Weight Obese syndrome. Curr Pharm Des 2008; 14: 2699-2706
43. De Lorenzo A, Del Gobbo V, Premrov MG, Bigioni M, Galvano F, Di Renzo L. Normal weight obese syndrome: an early inflammation? Am J Clin Nutr 2007; 85: 40-45
44. Juge-Aubry CE, Henrichot E, Meier CA. Adipose tissue: a regulator of inflammation. Best Pract Res Clin Endocrinol Metab 2005; 19: 547-566
45. Packer L, Kraemer K, Rimbach G. Molecular aspects of lipoic acid in the prevention of diabetes complications. Nutrition 2001; 17: 888-895
46. Holmquist L, Stuchbury G, Berbaum K. Lipoic acid as a novel treatment for Alzheimer's disease and related dementias. Pharmacol Ther 2007; 113: 154-164
47. Bilska A, Wlodek L. Lipoic acid -the drug of the future? Pharmacol Rep 2005; 57: 570-577
48. Cho KJ, Moon HE, Moini H, Packer L, Yoon DY, Chung AS. α-Lipoic acid inhibits adipocyte differentiation by regulating pro-adipogenic transcription factors via mitogen-activated protein kinase pathways. J Biol Chem 2003; 278: 34823-34833